-
Mashup Score: 1Is re-treatment possible with anti-CD38 therapies? - 4 year(s) ago
During the 6th World Congress on Controversies in Multiple Myeloma (COMy), the Multiple Myeloma Hub spoke to Saad Usmani, Levine Cancer Institute, Charlotte, US. We asked, Is re-treatment possible with anti-CD38 therapies?
Source: multiplemyelomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Updates on the HORIZON study: melflufen in R/R multiple myeloma - 4 year(s) ago
Paul Richardson, MD, Dana-Farber Cancer Institute, Boston, MA, provides updates on the multicenter, international HORIZON study (NCT02963493). The study aims…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Updates on the HORIZON study: melflufen in R/R #MultipleMyeloma w/ Paul Richardson of @DanaFarber: https://t.co/FP913AFUaa @COMyCongress #COMy20 #MMsm #Myeloma #OncoAlert @OncoAlert #CTsm
-
-
Mashup Score: 8The next five years of multiple myeloma treatment - 4 year(s) ago
Graham Jackson, MBBS, FRCP, FRCPath, MD, Newcastle upon Tyne Hospitals NHS Trust, Newcastle, UK, discusses the future developments of multiple…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: The next five years of #MultipleMyeloma treatment w/ @profghjackson of @NewcastleHosps: https://t.co/gRYbvjpxtr @COMyCongress #COMy20 #MMsm #Myeloma #OncoAlert @OncoAlert #ImmunOnc
-
-
Mashup Score: 0
Giampaolo Merlini, MD, Foundation IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy, discusses the importance of an early diagnosis…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: The importance of early diagnosis for improved light chain #Amyloidosis survival w/ Giampaolo Merlini: https://t.co/uZBirTxr4s @COMyCongress #COMy20 #OncoAlert @OncoAlert
-
-
Mashup Score: 0The impact of CHIP expression on multiple myeloma treatment - 4 year(s) ago
Irene Ghobrial, MD, Dana-Farber Cancer Institute, Boston, MA, discusses stem cell mutations and their implications for treating multiple myeloma. With…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: The impact of CHIP expression on #MultipleMyeloma treatment w/ @IreneGhobrial of @DanaFarber: https://t.co/HwXsjljYLO @COMyCongress #COMy20 #MMsm #Myeloma #OncoAlert @OncoAlert
-
-
Mashup Score: 1
Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, discusses promising clinical trials in cellular therapies for multiple myeloma. The Phase…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Promising clinical trials for #MultipleMyeloma: KarMMa, CARTITUDE and EVOLVE w/ @NoopurRajeMD of @MassGeneralNews: https://t.co/malQUSXh93 @COMyCongress #COMy20 #MMsm #Myeloma #OncoAlert @OncoAlert #CTsm #ImmunOnc
-
-
Mashup Score: 0The importance of MRD in multiple myeloma management - 4 year(s) ago
Jesus San Miguel, MD, Universidad de Navarra, Navarra, Spain, highlights the importance of measurable residual disease (MRD) in the management…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: The importance of #MRD in multiple #Myeloma management w/ Jesus San Miguel of @ClinicaNavarra: https://t.co/HsWpyUfPnI #HemOnc #MMsm @COMyCongress #COMy20 #OncoAlert #Myeloma #MultipleMyeloma #OncoAlert @OncoAlert
-
-
Mashup Score: 10COMy 2020 highlights: smoldering myeloma, MRD and immunotherapy - 4 year(s) ago
Arnon Nagler, MD, Chaim Sheba Medical Center, Tel-Aviv, Israel, gives an overview of the topics discussed during the COMy 2020…
Source: VJHemOncCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @VJHemOnc: VIDEO: COMy 2020 highlights: smoldering #Myeloma, #MRD and immunotherapy w/ Arnon Nagler of @SHEBA_: https://t.co/4bxlrv4WCw…
-
VIDEO: COMy 2020 highlights: smoldering #Myeloma, #MRD and immunotherapy w/ Arnon Nagler of @SHEBA_: https://t.co/4bxlrv4WCw #HemOnc #MMsm @COMyCongress #COMy20 #OncoAlert #Myeloma #MultipleMyeloma #ImmunoOnc
-
-
Mashup Score: 1Management of AL amyloidosis: what’s new? - 4 year(s) ago
Giampaolo Merlini, MD, Foundation IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy, discusses recent advances in the management of…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Management of AL #Amyloidosis: what’s new? w/ Giampaolo Merlini: https://t.co/CrLMMqB0vl #HemOnc #CTsm @COMyCongress #COMy20 #OncoAlert
-
-
Mashup Score: 1
Sagar Lonial, MD, Winship Cancer Institute of Emory University, Atlanta, GA, discusses the future of CAR T-cells and bispecific antibodies…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: The future of CAR T-cells and bispecific antibodies to treat myeloma w/ @SagarLonialMD of @WinshipAtEmory: https://t.co/DfUAxjJlSF #HemOnc #MMsm @COMyCongress #COMy20 #OncoAlert #Myeloma #MultipleMyeloma #ImmunoOnc
-
CONGRESS | #COMy20 | 👀 Watch the @MM_Hub interview with @szusmani, @LevineCancer. We asked: ‘Is re-treatment possible with anti-CD38 therapies?’ https://t.co/M2LTw60BgR #mmsm #myeloma https://t.co/ubhkIx7nE7